Literature DB >> 20136631

Self-emulsifying drug delivery systems (SEDDS): formulation development, characterization, and applications.

Bhupinder Singh1, Shantanu Bandopadhyay, Rishi Kapil, Ramandeep Singh, O Katare.   

Abstract

Self-emulsifying drug delivery systems (SEDDS) possess unparalleled potential in improving oral bioavailability of poorly water-soluble drugs. Following their oral administration, these systems rapidly disperse in gastrointestinal fluids, yielding micro- or nanoemulsions containing the solubilized drug. Owing to its miniscule globule size, the micro/nanoemulsifed drug can easily be absorbed through lymphatic pathways, bypassing the hepatic first-pass effect. We present an exhaustive and updated account of numerous literature reports and patents on diverse types of self-emulsifying drug formulations, with emphasis on their formulation, characterization, and systematic optimization strategies. Recent advancements in various methodologies employed to characterize their globule size and shape, ability to encapsulate the drug, gastrointestinal and thermodynamic stability, rheological characteristics, and so forth, are discussed comprehensively to guide the formula-tor in preparing an effective and robust SEDDS formulation. Also, this exhaustive review offers an explicit discussion on vital applications of the SEDDS in bioavailability enhancement of various drugs, outlining an overview on myriad in vitro, in situ, and ex vivo techniques to assess the absorption and/ or permeation potential of drugs incorporated in the SEDDS in animal and cell line models, and the subsequent absorption pathways followed by them. In short, the current article furnishes an updated compilation of wide-ranging information on all the requisite vistas of the self-emulsifying formulations, thus paving the way for accelerated progress into the SEDDS application in pharmaceutical research.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20136631     DOI: 10.1615/critrevtherdrugcarriersyst.v26.i5.10

Source DB:  PubMed          Journal:  Crit Rev Ther Drug Carrier Syst        ISSN: 0743-4863            Impact factor:   4.889


  23 in total

Review 1.  Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals.

Authors:  Shu Wang; Rui Su; Shufang Nie; Ming Sun; Jia Zhang; Dayong Wu; Naima Moustaid-Moussa
Journal:  J Nutr Biochem       Date:  2013-11-05       Impact factor: 6.048

2.  Evaluation of self-emulsified DIM-14 in dogs for oral bioavailability and in Nu/nu mice bearing stem cell lung tumor models for anticancer activity.

Authors:  Apurva R Patel; Ravi Doddapaneni; Terrick Andey; Heather Wilson; Stephen Safe; Mandip Singh
Journal:  J Control Release       Date:  2015-06-14       Impact factor: 9.776

3.  Evaluation of Spray BIO-Max DIM-P in Dogs for Oral Bioavailability and in Nu/nu Mice Bearing Orthotopic/Metastatic Lung Tumor Models for Anticancer Activity.

Authors:  Apurva R Patel; Chandraiah Godugu; Heather Wilson; Stephen Safe; Mandip Singh
Journal:  Pharm Res       Date:  2015-01-10       Impact factor: 4.200

4.  Enhanced Oral Bioavailability of β-Caryophyllene in Healthy Subjects Using the VESIsorb® Formulation Technology, a Novel Self-Emulsifying Drug Delivery System (SEDDS).

Authors:  Yvonne Mödinger; Katharina Knaub; Tanita Dharsono; Roland Wacker; Remo Meyrat; M Hunter Land; Anthony L Petraglia; Christiane Schön
Journal:  Molecules       Date:  2022-04-30       Impact factor: 4.927

5.  Development and evaluation of avanafil self-nanoemulsifying drug delivery system with rapid onset of action and enhanced bioavailability.

Authors:  Usama A Fahmy; Osama A A Ahmed; Khaled M Hosny
Journal:  AAPS PharmSciTech       Date:  2014-08-29       Impact factor: 3.246

6.  Novel cationic supersaturable nanomicellar systems of raloxifene hydrochloride with enhanced biopharmaceutical attributes.

Authors:  Atul Jain; Rajpreet Kaur; Sarwar Beg; Varun Kushwah; Sanyog Jain; Bhupinder Singh
Journal:  Drug Deliv Transl Res       Date:  2018-06       Impact factor: 4.617

7.  The Role of Self-Nanoemulsifying Drug Delivery Systems of CDODA-Me in Sensitizing Erlotinib-Resistant Non-Small Cell Lung Cancer.

Authors:  Ebony Nottingham; Vasanthakumar Sekar; Arindam Mondal; Stephen Safe; Arun K Rishi; Mandip Singh
Journal:  J Pharm Sci       Date:  2020-01-15       Impact factor: 3.534

8.  Development Of Saquinavir Mesylate Nanoemulsion-Loaded Transdermal Films: Two-Step Optimization Of Permeation Parameters, Characterization, And Ex Vivo And In Vivo Evaluation.

Authors:  Khaled M Hosny
Journal:  Int J Nanomedicine       Date:  2019-11-01

9.  Formulation development for the orexin receptor antagonist almorexant: assessment in two clinical studies.

Authors:  Jasper Dingemanse; Martine Gehin; Hans Gabriel Cruz; Petra Hoever
Journal:  Drug Des Devel Ther       Date:  2014-04-28       Impact factor: 4.162

10.  A novel self-nanoemulsifying drug delivery system for curcumin used in the treatment of wound healing and inflammation.

Authors:  Niyaz Ahmad; Rizwan Ahmad; Ali Al-Qudaihi; Salman Edrees Alaseel; Ibrahim Zuhair Fita; Mohammed Saifuddin Khalid; Faheem Hyder Pottoo; Srinivasa Rao Bolla
Journal:  3 Biotech       Date:  2019-09-09       Impact factor: 2.893

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.